1) The document discusses differentiating between true muscle weakness and fatigue, and provides an algorithmic approach to evaluating the cause of weakness.
2) Key points include differentiating acute vs. chronic onset, unilateral vs. bilateral involvement, and determining if signs are upper or lower motor neuron.
3) Common causes discussed include stroke, spinal cord lesions, peripheral neuropathies, myasthenia gravis, and myopathies. The algorithm provides guidance on determining the localization and cause based on history and exam findings.
MYOPATHIES A SPECIAL AND SEPERATE ENTITY WITH SPECIFIC FEATURES IN EACH DISORDER MAKING US EASY FOR DIAGNOSIS,CONFIRMATION BY MUSCLE BIOPSY.THE SEMINAR WAS PRSENTED ON 06/07/2011...AT 09.00AM
HAVE A LOOK ..AND COMMENT..WITHOUT BIAS..
MYOPATHIES A SPECIAL AND SEPERATE ENTITY WITH SPECIFIC FEATURES IN EACH DISORDER MAKING US EASY FOR DIAGNOSIS,CONFIRMATION BY MUSCLE BIOPSY.THE SEMINAR WAS PRSENTED ON 06/07/2011...AT 09.00AM
HAVE A LOOK ..AND COMMENT..WITHOUT BIAS..
Lecture by Prof. Osama Shukir Muhammed Amin FRCP(Edin), FRCP(Glasg), FRCP(Ire), FRCP(Lond), FACP, FAHA, to consolidate information pre-Task Based Learning about Limb Weakness. This lecture addresses lower motor neurons lesions and signs, their localization, and rationale for choosing diagnostic investigations. The next lecture will be about lower motor neuron lesions.
this presentation briefly discus about muscle and its related disorder. some myopathies which are common are cover here in an approach to provide basis of the same disease and treatment. this ppt is basically from chapter 32 zakazewski.
Lecture by Prof. Osama Shukir Muhammed Amin FRCP(Edin), FRCP(Glasg), FRCP(Ire), FRCP(Lond), FACP, FAHA, to consolidate information pre-Task Based Learning about Limb Weakness. This lecture addresses lower motor neurons lesions and signs, their localization, and rationale for choosing diagnostic investigations. The next lecture will be about lower motor neuron lesions.
this presentation briefly discus about muscle and its related disorder. some myopathies which are common are cover here in an approach to provide basis of the same disease and treatment. this ppt is basically from chapter 32 zakazewski.
Imaging of spinal cord acute myelopathiesNavni Garg
This presentation provides a comprehensive review of imaging of causes of acute myelopathies and a systemic approach for narrowing down the differentials
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
2. 2
Introduction:
• Weakness as professional/ medical term refer to symptom arise
from something wrong in muscle.
• In this situation very important to differentiate between
weakness & other confusing symptoms which mimic
weakness as said by patient, as fatigue.
• Weakness as mentioned before indicate the wrong is in the
muscle, either due to pathology with in muscle (myopathy), or
pathology in its motor nervous supply. So power of muscle will
be decreased according to MRC power rating system. This we
name it, objective muscle weakness, neuromuscular
weakness, true muscle weakness or clinical muscle
weakness (i.e: clinically detectable muscle weakness).
3. • Fatigue is subjective term reported by patient as weakness-like
complain felt after exercise but actually muscle power is
normal,
i.e: no pathology in muscle or in its nerve supply. So fatigue is
non- objective muscle weakness, non-neuromuscular
weakness, functional muscle weakness or false muscle
weakness.
Motor Nerve
Supply
3
True Muscle
Weakness Wrong neither
in muscle nor
in its nerve
supply
Function
al
Muscle
weaknes
s
[Myopathy
]
Muscl
e
4. 4
Why approach to weakness is very
important?
• Because stroke enter in differential diagnosis of weakness
which severe condition & current stroke management
mandates urgent evaluation of unilateral limb weakness.
5. 5
Classification by Algorithm-wise
Approach:
First of all keep in your mind the following helping questions:
• Mode of Onset & Duration:
oAcute: vascular, toxic & metabolic.
oChronic: neoplastic, infective, inflammatory, endocrine,
degenerative diseases.
• Course:
oWorse at onset then get regress later on: neurogenic cause:
vascular.
oProgressive: neurogenic cause: neoplasm, degenerative & infective
diseases.
oEpisodic: neurogenic cause: vascular.
oActivity dependent: NMJ cause: MG & muscular cause: myopathies.
7. 7
Reviews:
Stroke:
•Most common cause of unilateral weakness.
•Patients typically present with sudden onset of
the complains.
•If persist < 3 hours , then it will resolve (TIA),
while if persist > 3 hours, then it will not resolve
(true stroke).
•It can be cortical ,subcortical, brainstem or spinal
8. •How to approach stroke.
1. Identify nature
whether ischemic or hoemorrhagic. If
ischaemic then embolic or thrombotic.We have to ask
three question,1. time of stroke, 2.deficit at onset and
3.progression.
Thrombotic stroke usually occurs at 4 am, while embolic
and heomorrhagic usually during activity.
Embolic give rise to fixed deficit but deficit progresses in
thromotic.
9. LOCALIZATION
2. Site/localization. Before localization try to understand some words
The words are.
1. Hemilegia vs hemiparesis
2. Dense hemiplegia,brachial (upper limb more weaker than lower limb)
and crural (lower limb more weaker than upper limb) hemiplegia.
3.crossed (cranial nerve manifestation on one side and hemiplegia on
other side) and uncrossed hemiplegia (both cranial nerve manifestation
and hemiplegia on same side)
10.
11. All cranial nerves has dual/bilateral supply from
hemispheres except some part of facial and some
part of hypoglossus
12. • Now how to say that stroke is cortical,
The hemiplegia will be either crural or brachial and
there may be cortical dysfunction as mentioned below
1
2
13. -How to say internal capsule.
Answer is dense hemiplegia. No cortical
sign.
-Qustion, which site is more common for
thrombotic, cortical or internal capsule?
-How to say subcortical stroke??
14. Space-occupying lesions (SOL):
e.g. tumors, abscesses, chronic subdural
hematoma, can cause symptoms & signs
mimicking stroke but the onset is
typically more gradual
& progressive.
•There may be
features of raised
ICP.
10
20. can spinal cord lesion manifest as
hemiplegia
Yes, if hemicut above c5
21. 11
Spinal cord lesions:
•Above level of C5:
oHemicut: Ibsilateral UMN hemiparesis/ hemiplegia and
deep hemiparesthesia with contralateral superficial
hemiparesthesia.
oComplete cut: UMN quadriparesis/ quadriplegia with
bilateral loss
all sensation types.
N.B: If injury involve C3, C4 & C5, then patients will
be died (because these are root values of phrenic
nerve).
•C5 to T1 (brachial plexus):
oHemicut: ibsilateral LMN hemiparesis/ hemiplegia and deep
hemiparesthesia with contralateral superficial
hemiparesthesia in upper limbs & ibsilateral UMN
hemiparesis/ hemiplegia and deep hemiparesthesia with
contralateral superficial hemiparesthesia in lower limbs.
22. 12
o Complete Cut: bilateral LMN weakness with bilateral
loss of all sensation types in upper limbs & bilateral UMN
weakness with bilateral loss of all sensation types in
lower limbs.
•T2 to L1:
oHemicut (Brown Sequard syndrome): ibsilateral UMN or
LMN monoparesis/ monoplegia in lower limb with ibsilateral
deep sensory loss & contralateral sensory loss take sensory
level pattern on trunk & autonomic dysfunction symptoms.
oComplete cut: UMN (spastic) paraparesis/ paraplegia or
LMN (flaccid) paraparesis/ paraplegia with or without
sensory loss take sensory level pattern on trunk &
autonomic dysfunction symptoms.
24. 14
•Below L1 (Lumbosacral Plexus/ Cauda-Equina):
always LMN weakness in lower limbs unilaterally or bilaterally
but not to similar extent with sensory loss take “glove &
stocking” pattern & autonomic dysfunction symptoms.
26. Multiple Sclerosis (MS):
16
•Idiopathic inflammatory demyelinating disease of
white matter of the brain and spinal cord.
•Common in women between 20 – 40 years.
•Usually monosymptomatic.
•Characterized by relapsing & remitting course.
•Presented with motor, ocular sensory, cerebellar,
autonomic or cranial nerves abnormalities. The
ocular abnormality is the most common one.
•Can presented with almost any pattern of UMN
limb weakness, though paraparesis secondary
to TM is the most typical.
27. AHC Lesions; Motor Neuron Diseases (MND):
17
•It’s group of chronic degenerative diseases of
unknown
etiology affecting the motor system only.
•Characterized by gradual onset and progressive
weakness.
•Common in males > 50 years.
•Affect UMN or LMN or both. Can be presented with
bulbar symptoms.
•No sensory, cerebellar, autonomic or ocular
abnormalities.
28. Peripheral nerve lesions:
• Cause LMN limbs weakness.
• Can be caused by:
o Metabolic causes: DM, Renal failure, Hypoglycemia.
o Inflammatory causes: GBS, Sarcoidosis, Chronic
Inflammatory Demyelinating Polyradiculoneuropathy
(CIDP).
o Toxins: Botulism, Lead, Alcohol.
o Vasculitis: RA, PAN, Wegener’s granulomatosis.
o Drugs: INH, Phenytoin, Cisplatin.
o Congenital: Charcot Marie Tooth disease.
18
29. Guillain-barre Syndrome: 19
•It is acute ascending inflammatory
demyelinating polyneuropathy that
is autoimmune in nature.
•Can affect any age.
• Presentation is acute.
• H/O URTI, diarrhea,
vaccination 2 weeks before
the presentation.
• Symmetrical ascending
weakness of regressive course.
• Dyspnea is alarming sign.
30. 20
NMJ lesions; Myasthenia Gravis (MG):
•Autoimmune neuromuscular disorder
characterized by fatigable LMN muscle
weakness.
•Common in women between 20 – 40 years.
•Type of weakness is fatigable & of diurnal variation,
i.e: muscle power initially is normal then get
weakens with repeated activity to became true
weakness at end of day.
•Associated with ocular & bulbar symptoms & tend
to be affected before limb muscles.
•Occur as relapsing & remitting course
32. Remember that: 22
•Muscle Power: preserved in patients with cachexia
despite advanced generalized muscle atrophy. In
contrast, patients with true muscle weakness due to
myopathy have low muscle power generally have
normal muscle bulk at time of presentation.
•Muscle Tenderness: usually not associated with one
of the causes of true muscle weakness, except for
infectious myopathies, certain drug- induced
myopathies, rhabdomyolysis, thyroid myopathy, and
inherited metabolic myopathies.
33. Diagnosis By
Algorithm-
wise
Approach:
Patient complain
of weakness
Is the weakness,
true?
Is the true weakness
is strictly
unilateral?
Unilateral
weakness
Do blood
sugar
test
This mean cortical
stroke excluded by far
extent & lesion is in
spinal cord
(paraparesis/
paraplegia)
Is the onset,
sudden?
Is it associated with features of acute limb
ischemia (pain, cold, pale, mottled skin &
absent pulse)?
Request vascular
surgeon
consultation
Urgent Spine
MRI
• Cord compression
• Intrinsic spinal cord pathology
(Syringomyelia, TM, glioma,
abscess)
Immobilize patient
& do cervical
spine image if
there is h/o
trauma
Severe back pain +
sparing of proprioception
& vibration?
Request neurosurgeon
or oncologist
consultation
Spinal
infarction
Are there UMN
signs?
Is it associated with
sensory level & sphincter
disturbance?
Is there MRI
evidence
of
myelopathy?
• Cord compression
• Intrinsic spinal cord pathology
(Syringomyelia, TM, glioma,
abscess)
• SCDD
(plasma
vitamin B12)
• Post-
radiotherapy
myelopathy
(Hx)
• MND; ALS (Hx
&
Ex)
Bilateral intracranial
lesions: cerebral
emboli/ metz, venous
stroke, demyelination/
MS (Hx & Ex and brain
image)
This is mean LMN
signs
Are there sensory
s/s?
Peripheral
neuropathy (distal
weakness):
GBS (Hx, Ex, NCS,
LP,
vital capacity monitor)
Refer to neurologist
CIDP (Hx, Ex, NCS,
FBS,
HIV test, urinary
porphyrin,
serum protein
electrophoresis)
Refer to neurologist
Bilateral
radiculopathy (Hx,
Ex, spinal cord
image)
Refer to neurologist
Otherwise:
• Ask about drugs/ alcohol Hx, family Hx of
charcot’s disease, social Hx of lead exposure
…etc
• Request following Ix: FBC, BS, U,E&C,
ESR, CRP, Ca, RF, TFT
Is there muscle
fatigability (fatigable/
post-exercise
weakness)?
Tendon reflexes?
MG (Hx, Ex,
tensilon test,
EMG, anti-
Ach receptor
AB, thoracic
CT)
LEMS (anti-
voltage-
gated
calcium
channels
AB, EMG,
screen
underlying
malignancy)
Proximal
weakness
?
Myopathies
Hx: bedridden patient, drugs/
alcohol hx, past medical hx,
past surgical hx, h/o trauma
…etc
Ix: FBC, U,E&C, ESR, CRP,
BS, Ca, RF, TFT, CK,
EMG • Infective myopathy (FBC, ESR, PCT)
• Some drugs induced myopathy (statin)
• Myositis; polymyositis,
dermatomyositis (anti-synthetase
AB)
• Insist on considering peripheral neuropathy, MND, mononeuritis multiplex,
myopathies, generalized weakness secondary to acute illness, functional
weakness.
• Refer to neurologist if no cause identified.
Ye
s
Functional weakness
(fatigue)
No
Ye
s
Ye
s
No
Ye
s
No
Ye
s
Ye
s
No
Ye
s
No
Ye
s
No
Ye
s
No
No
No
Ye
s
Absen
t
Normal
Ye
s
No
No
Is there weight
Loss?
Is there
pallor?
Anemia
s
MG
Drugs/ alcohol
Hx?
• Alcohol
• Cocaine
abuse
• Chronic
aspirin
ingestion
• Anxiety
• Depression
• Fibromyalgia
• Aldosteronism
Is there fever?
• TB
• SBE
• Collagen
diseases
• Other infections
Neurologic
findings?
Is there
Polyuria?
• Hyperthyroidism
• DM
• DI
• Hyperparathyroidism
• CKD
• Electrical
disturbances
• Neoplasm
• Malnutrition
• Addison’s disease
• Cirrhosis
• Malabsorption syndrome
• CHF
• Parkinson’s
disease
• Muscular
dystrophy
• MND (ALS)
• MS
• Neuropathies
No Yes
No Ye
s
Is the fatigue
constant?
Yes No
+ve -ve
Ye
s
No
-ve
+ve
No
Ye
s
Is the onset,
sudden?
Is it
painful
?
Ischemia (compare pulse &
capillary refilling between 2
limbs)
Refer to vascular
surgeon
Fracture (Hx of trauma & do X-
ray)
Refer to orthopedist
Compartment syndrome (CK
level in blood)
Stroke TIA
Are there seizure,
evidence of increased
ICP, cortical
dysfunction or CNS
infection?
• SOL
• Meningoencephaliti
s (fever, purpuric
skin rashes &
meningeal irritation
signs)
• LP
• Neuroimage
Are there UMN
signs?
Is there contralateral sensory
loss?
Unilateral spinal cord
lesions
MRI
Spine
• Ipsilateral sensory loss: SOL, stroke,
MS
• Normal sensation: MND
Is signs are referable
to single nerve root/
single nerve?
Radiculopathy or mononeuropathy
• Insist on considering plexopathy, multi-root
compression, MND, stroke, migraine, functional
weakness.
• Refer to neurologist if no cause identified.
Ye
s
Ye
s
Is duration > 3 hours?
Yes No
No
Ye
s
No
Ye
s
Ye
s
No
No
No
Ye
s
MRI
Spine
Ye
s No
Muscle
Tenderness
No
Other myopathies
Ye
s
No
MotorCortex
Spinal
Cord
Peripheral
Nerves
NM
J
Muscle
Bilateral True
Weakness
Unilateral True
Weakness
Functional
Weakness
23
35. Sources: 24
• Macleod's Clinical Diagnosis 2nd Ed (2013)
• Approach to Internal Medicine 4th Ed (2015)
• Algorithmic Diagnosis of Symptoms and Signs 4th Ed
(2017)
• Toronto Notes 34th Ed (2018)
• Ain-Shams University Internal Medicine curriculum
(2014)
• Decision Making in Medicine 3rd Ed (2010)